Results from this phase showed 88% of mice rejected pancreatic tumors, 75% rejected breast tumors, and 69% rejected melanoma. All tumor-free mice also resisted further cancer spread.
The research, funded by the National Institutes of Health, was supported by UMass Amherst’s Biomedical Engineering Department, the Institute for Applied Life Sciences and UMass Chan Medical School. Findings were published Oct. 9 in Cell Reports Medicine.
You must log in or # to comment.
It’ll cost $20 to produce per dose, and they’ll charge $2000 per dose.
Only in the US. The rest of the world will get them at a reasonable price.